Cargando…
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. METHODS: We conducted a secondary analysis of an international, multicent...
Autores principales: | Di Pasquale, Marta Francesca, Sotgiu, Giovanni, Gramegna, Andrea, Radovanovic, Dejan, Terraneo, Silvia, Reyes, Luis F, Rupp, Jan, González del Castillo, Juan, Blasi, Francesco, Aliberti, Stefano, Restrepo, Marcos I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481991/ https://www.ncbi.nlm.nih.gov/pubmed/31222287 http://dx.doi.org/10.1093/cid/ciy723 |
Ejemplares similares
-
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2018) -
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2020) -
An international perspective on hospitalized patients with viral community-acquired pneumonia
por: Radovanovic, Dejan, et al.
Publicado: (2019) -
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
por: Aliberti, Stefano, et al.
Publicado: (2020) -
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)